图书馆订阅: Guest
肿瘤形成评论综述™

每年出版 4 

ISSN 打印: 0893-9675

ISSN 在线: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Gaucher Disease and Malignancy: A Model for Cancer Pathogenesis in an Inborn Error of Metabolism

卷 18, 册 3, 2013, pp. 235-246
DOI: 10.1615/CritRevOncog.2013006145
Get accessGet access

摘要

Clinical observations spanning almost half a century have demonstrated a consistent association of type 1 Gaucher disease (GD1) and cancers. However, the cellular and molecular bases of the association are not understood. Gaucher disease (GD) is a lysosomal storage disorder due to an inherited deficiency of acid β-glucosidase that underlies the accumulation of glucosylceramide in lysosomes of mononuclear phagocytes and immune dysregulation. The overall cancer risk is markedly increased in GD, and the determinants of malignancy in a subset of patients with GD1 are not known. The association of GD and cancer is most striking for hematological malignancies, with the risk for multiple myeloma estimated at almost 37-fold compared to the general population; some studies have also suggested increased cancer risk for non-hematological malignancies. There is no association of overall severity of GD to risk of cancer, although there is an increased prevalence of splenectomy among patients exhibiting the GD/cancer phenotype. Moreover, there appears to be an increased incidence of multiple consecutive cancers in individual patients. Several factors could contribute to cancer development in GD, including polarization of macrophages to the alternatively activated phenotype, chronic inflammation, chronic B-cell stimulation, splenectomy, hyperferritinemia, lysosomal dysfunction, and endoplasmic reticulum stress. Recent studies have highlighted T-cell dysfunction and modifier genes contributing to an increased cancer risk in GD. Macrophage-targeted enzyme replacement therapy (ERT) reverses systemic features of GD1; while cancer risk appears to be reduced in the era of ERT, it is not known whether this is a direct effect of therapy. Delineation of the mechanisms underlying the increased cancer risk in GD will provide additional novel insights into the role of lipids and macrophages in cancer pathogenesis and, moreover, have the potential to reveal novel therapeutic targets.

对本文的引用
  1. Shayman James A, Eliglustat tartrate, a prototypic glucosylceramide synthase inhibitor, Expert Review of Endocrinology & Metabolism, 8, 6, 2013. Crossref

  2. Siebert Marina, Sidransky Ellen, Westbroek Wendy, Glucocerebrosidase is shaking up the synucleinopathies, Brain, 137, 5, 2014. Crossref

  3. Cox T.M., Lysosomal Diseases, in Encyclopedia of Cell Biology, 2016. Crossref

  4. Bettman Noam, Avivi Irit, Rosenbaum Hanna, Bisharat Lina, Katz Tamar, Impaired migration capacity in monocytes derived from patients with Gaucher disease, Blood Cells, Molecules, and Diseases, 55, 2, 2015. Crossref

  5. Cox Timothy M., Rosenbloom Barry E., Barker Roger A., Gaucher disease and comorbidities: B-cell malignancy and parkinsonism, American Journal of Hematology, 90, 2015. Crossref

  6. Mistry Pramod K., Belmatoug Nadia, vom Dahl Stephan, Giugliani Roberto, Understanding the natural history of Gaucher disease, American Journal of Hematology, 90, 2015. Crossref

  7. Linari Silvia, Castaman Giancarlo, Hematological manifestations and complications of Gaucher disease, Expert Review of Hematology, 9, 1, 2016. Crossref

  8. Nair Shiny, Boddupalli Chandra Sekhar, Verma Rakesh, Liu Jun, Yang Ruhua, Pastores Gregory M., Mistry Pramod K., Dhodapkar Madhav V., Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation, Blood, 125, 8, 2015. Crossref

  9. Salio Mariolina, Cerundolo Vincenzo, NKT-dependent B-cell activation in Gaucher disease, Blood, 125, 8, 2015. Crossref

  10. Argmann Carmen A., Houten Sander M., Zhu Jun, Schadt Eric E., A Next Generation Multiscale View of Inborn Errors of Metabolism, Cell Metabolism, 23, 1, 2016. Crossref

  11. Regenboog Martine, Bohte Anneloes E., Somers Inne, van Delden Otto M., Maas Mario, Hollak Carla E.M., Imaging characteristics of focal splenic and hepatic lesions in type 1 Gaucher disease, Blood Cells, Molecules, and Diseases, 60, 2016. Crossref

  12. Nair Shiny, Branagan Andrew R., Liu Jun, Boddupalli Chandra Sekhar, Mistry Pramod K., Dhodapkar Madhav V., Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma, New England Journal of Medicine, 374, 6, 2016. Crossref

  13. Dhodapkar Madhav V., MGUS to myeloma: a mysterious gammopathy of underexplored significance, Blood, 128, 23, 2016. Crossref

  14. Korula Sophy, Owens Penny, Charlton Amanda, Bhattacharya Kaustuv, Rare Case of Hepatic Gaucheroma in a Child on Enzyme Replacement Therapy, in JIMD Reports, Volume 32, 32, 2016. Crossref

  15. Ozawa Michael G., Cooney Tabitha, Rangaswami Arun, Hazard Florette K., Synchronous Hepatoblastoma, Neuroblastoma, and Cutaneous Capillary Hemangiomas: A Case Report, Pediatric and Developmental Pathology, 19, 1, 2016. Crossref

  16. Madeo Annalisa, Garaventa Alberto, Sementa Angela Rita, Suffia Chiara, Di Rocco Maja, The unusual association between Neuroblastoma and Gaucher Disease: Case report and review of the literature, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  17. Murugesan Vagishwari, Lischuk Andrew, Haims Andrew, Lackman Richard, Brooks John S., Mankin Henry, Mistry Pramod K., Case series and literature review of skeletal tumors and their incidence in the Gaucher disease population, American Journal of Hematology, 91, 7, 2016. Crossref

  18. Regenboog Martine, van Kuilenburg André B.P., Verheij Joanne, Swinkels Dorine W., Hollak Carla E.M., Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications, Blood Reviews, 30, 6, 2016. Crossref

  19. Mistry Pramod K., Lopez Grisel, Schiffmann Raphael, Barton Norman W., Weinreb Neal J., Sidransky Ellen, Gaucher disease: Progress and ongoing challenges, Molecular Genetics and Metabolism, 120, 1-2, 2017. Crossref

  20. Klimkowska Monika, Machaczka Maciej, Palmblad Jan, Aberrant bone marrow vascularization patterns in untreated patients with Gaucher disease type 1, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  21. Bird Sarah, Hadjimichael Efthymios, Mehta Atul, Ramaswami Uma, Hughes Derralynn, Fabry disease and incidence of cancer, Orphanet Journal of Rare Diseases, 12, 1, 2017. Crossref

  22. Hannibal Luciana, Siebert Marina, Basgalupp Suélen, Vario Filippo, Spiekerkoetter Ute, Blom Henk J., Hampered Vitamin B12 Metabolism in Gaucher Disease?, Journal of Inborn Errors of Metabolism and Screening, 5, 2017. Crossref

  23. Nair Shiny, Dhodapkar Madhav V., Natural Killer T Cells in Cancer Immunotherapy, Frontiers in Immunology, 8, 2017. Crossref

  24. Hasiński Piotr, Bik-Multanowski Mirosław, Koba-Wszędobył Magdalena, Walczak Mieczysław, Bubnowski Marek, Milewska-Kranc Agnieszka, Smyk Andrzej, Machaczka Maciej, Choroba Gauchera – zalecenia dotyczące rozpoznawania, leczenia i monitorowania, Acta Haematologica Polonica, 48, 4, 2017. Crossref

  25. Pandey Manoj K., Burrow Thomas A., Rani Reena, Martin Lisa J., Witte David, Setchell Kenneth D., Mckay Mary A., Magnusen Albert F., Zhang Wujuan, Liou Benjamin, Köhl Jörg, Grabowski Gregory A., Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease, Nature, 543, 7643, 2017. Crossref

  26. Camelo Júnior José Simon, Dragosky Marta, Drelichman Guillermo, DOENÇA DE GAUCHER TIPO 1 NO ESQUELETO: REVISÃO DA AMÉRICA LATINA, Coluna/Columna, 15, 4, 2016. Crossref

  27. Dhodapkar Madhav V., Kumar Vipin, Type II NKT Cells and Their Emerging Role in Health and Disease, The Journal of Immunology, 198, 3, 2017. Crossref

  28. Kato Shingo, Berzofsky Jay A., Terabe Masaki, Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity, Frontiers in Immunology, 9, 2018. Crossref

  29. Kakizaki Satoru, Horiguchi Norio, Uehara Daisuke, Kanayama Yuuki, Kobayashi Takeshi, Tojima Hiroki, Yamazaki Yuichi, Sato Ken, Uraoka Toshio, Otsu Yoshiaki, Ida Hiroyuki, A patient with type I Gaucher disease who switched from enzyme replacement therapy to substrate reduction therapy after having of CYP2D6 polymorphisms checked, Kanzo, 59, 5, 2018. Crossref

  30. Nair Shiny, Sng Joel, Boddupalli Chandra Sekhar, Seckinger Anja, Chesi Marta, Fulciniti Mariateresa, Zhang Lin, Rauniyar Navin, Lopez Michael, Neparidze Natalia, Parker Terri, Munshi Nikhil C., Sexton Rachael, Barlogie Bart, Orlowski Robert, Bergsagel Leif, Hose Dirk, Flavell Richard A., Mistry Pramod K., Meffre Eric, Dhodapkar Madhav V., Antigen-mediated regulation in monoclonal gammopathies and myeloma, JCI Insight, 3, 8, 2018. Crossref

  31. Regenboog Martine, van Dussen Laura, Verheij Joanne, Weinreb Neal J., Santosa David, vom Dahl Stephan, Häussinger Dieter, Müller Meike N., Canbay Ali, Rigoldi Miriam, Piperno Alberto, Dinur Tama, Zimran Ari, Mistry Pramod K., Salah Karima Yousfi, Belmatoug Nadia, Kuter David J., Hollak Carla E. M., Hepatocellular carcinoma in Gaucher disease: an international case series, Journal of Inherited Metabolic Disease, 41, 5, 2018. Crossref

  32. Davidson Brad A., Hassan Shahzeb, Garcia Eric Joshua, Tayebi Nahid, Sidransky Ellen, Exploring genetic modifiers of Gaucher disease: The next horizon, Human Mutation, 39, 12, 2018. Crossref

  33. Noya MSoledad, Andrade-Campos Marcio, Irun Pilar, López de Frutos Laura, López-Fernandez MFernanda, Giraldo Pilar, Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously, Clinical Case Reports, 6, 5, 2018. Crossref

  34. Degnan Andrew J., Ho-Fung Victor M., Ahrens-Nicklas Rebecca C., Barrera Christian A., Serai Suraj D., Wang Dah-Jyuu, Ficicioglu Can, Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement, Insights into Imaging, 10, 1, 2019. Crossref

  35. Winter Aaron W, Salimi Ali, Ospina Luis H, Roos Jonathan C P, Ophthalmic manifestations of Gaucher disease: the most common lysosomal storage disorder, British Journal of Ophthalmology, 103, 3, 2019. Crossref

  36. Barwick Benjamin G., Gupta Vikas A., Vertino Paula M., Boise Lawrence H., Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma, Frontiers in Immunology, 10, 2019. Crossref

  37. Lai Michele, La Rocca Veronica, Amato Rachele, Freer Giulia, Pistello Mauro, Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities, International Journal of Molecular Sciences, 20, 14, 2019. Crossref

  38. Shirshev S. V., Mechanisms of Antiphospholipid Syndrome Induction: Role of NKT Cells, Biochemistry (Moscow), 84, 9, 2019. Crossref

  39. Wątek Marzena, Piktel Ewelina, Wollny Tomasz, Durnaś Bonita, Fiedoruk Krzysztof, Lech-Marańda Ewa, Bucki Robert, Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development, International Journal of Molecular Sciences, 20, 4, 2019. Crossref

  40. Wątek Marzena, Piktel Ewelina, Barankiewicz Joanna, Sierlecka Ewa, Kościołek-Zgódka Sylwia, Chabowska Anna, Suprewicz Łukasz, Wolak Przemysław, Durnaś Bonita, Bucki Robert, Lech-Marańda Ewa, Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma, International Journal of Molecular Sciences, 20, 23, 2019. Crossref

  41. Ryan Emory, Seehra Gurpreet Kaur, Sidransky Ellen, Mutations, modifiers and epigenetics in Gaucher disease: Blurred boundaries between simple and complex disorders, Molecular Genetics and Metabolism, 128, 1-2, 2019. Crossref

  42. Jaffe Dena H, Flaks-Manov Natalie, Benis Arriel, Gabay Hagit, DiBonaventura Marco, Rosenbaum Hanna, Joseph Alain, Bachrach Asaf, Leventer-Roberts Maya, Population-based cohort of 500 patients with Gaucher disease in Israel, BMJ Open, 9, 1, 2019. Crossref

  43. Nair Shiny, Bar Noffar, Xu Mina L., Dhodapkar Madhav, Mistry Pramod K., Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy, Molecular Genetics and Metabolism, 129, 4, 2020. Crossref

  44. Abell Katherine, Chadwell Sarah E., Burrow Thomas Andrew, Becker Ana Paula Pizzio, Bailey Laurie, Steele Paul, Zhang Xue, Islas‐Ohlmayer Miguel, Bittencourt Rosane, Schwartz Ida Vanessa Doederlein, Prada Carlos E., Outcomes of screening for gammopathies in children and adults with Gaucher disease type 1 in a cohort from Brazil and the United States, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 184, 4, 2020. Crossref

  45. Da Vià Matteo C., Ziccheddu Bachisio, Maeda Akihiro, Bagnoli Filippo, Perrone Giulia, Bolli Niccolò, A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity, HemaSphere, 4, 6, 2020. Crossref

  46. Allain-Maillet Sophie, Bosseboeuf Adrien, Mennesson Nicolas, Bostoën Mégane, Dufeu Laura, Choi Eun Ho, Cleyrat Cédric, Mansier Olivier, Lippert Eric, Le Bris Yannick, Gombert Jean-Marc, Girodon François, Pettazzoni Magali, Bigot-Corbel Edith, Hermouet Sylvie, Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms, Cancers, 12, 9, 2020. Crossref

  47. Andrade-Campos Marcio, Escuder-Azuara Beatriz, de Frutos Laura López, Serrano-Gonzalo Irene, Giraldo Pilar, Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?, Blood Cells, Molecules, and Diseases, 85, 2020. Crossref

  48. Bonesteele Grant, Gargus J. Jay, Curtin Emily, Tang Mabel, Rosenbloom Barry, Kimonis Virginia, Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease, Molecular Genetics and Metabolism Reports, 25, 2020. Crossref

  49. Sun Angela, Chang Irene J., Lam Christina, Berry Gerard T., Lysosomal Storage Disorders, in Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics, 2021. Crossref

  50. Serfecz Jacquelyn C., Saadin Afsoon, Santiago Clayton P., Zhang Yuji, Bentzen Søren M., Vogel Stefanie N., Feldman Ricardo A., C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages, International Journal of Molecular Sciences, 22, 18, 2021. Crossref

  51. Yazal Erdem Arzu, Özyörük Derya, Ovarian Mucinous Carcinoma in a Pediatric Patient With Maroteaux-Lamy Syndrome, Journal of Pediatric Hematology/Oncology, 43, 8, 2021. Crossref

  52. Kocic Marija, Djuricic Slavisa M, Djordjevic Maja, Savic Djordje, Kecman Bozica, Sarajlija Adrijan, Appendiceal involvement in a patient with Gaucher disease, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  53. Puri Ratna Dua, Kapoor Seema, Kishnani Priya S., Dalal Ashwin, Gupta Neerja, Muranjan Mamta, Phadke Shubha R., Sachdeva Anupam, Verma Ishwar C., Mistry Pramod K., Diagnosis and Management of Gaucher Disease in India – Consensus Guidelines of the Gaucher Disease Task Force of the Society for Indian Academy of Medical Genetics and the Indian Academy of Pediatrics, Indian Pediatrics, 55, 2, 2018. Crossref

  54. Holubar Jan, Bres Virginie, Costes-Martineau Valérie, Pers Yves-Marie, Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  55. Giraldo Pilar, Andrade-Campos Marcio, Novel Management and Screening Approaches for Haematological Complications of Gaucher’s Disease, Journal of Blood Medicine, Volume 12, 2021. Crossref

  56. Langeveld Mirjam, Elstein Deborah, Szer Jeff, Hollak Carla E.M., Zimran Ari, Classifying the additional morbidities of Gaucher disease, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  57. Žnidar Irena, Collin-Histed Tanya, Niemeyer Pascal, Parkkinen Johanna, Lauridsen Anne-Grethe, Zariņa Sandra, Cohen Yossi, Manuel Jeremy, The European Gaucher Alliance: a survey of member patient organisations’ activities, healthcare environments and concerns, Orphanet Journal of Rare Diseases, 9, 1, 2014. Crossref

  58. D’Amore Simona, Page Kathleen, Donald Aimée, Taiyari Khadijeh, Tom Brian, Deegan Patrick, Tan Chong Y., Poole Kenneth, Jones Simon A., Mehta Atul, Hughes Derralynn, Sharma Reena, Lachmann Robin H., Chakrapani Anupam, Geberhiwot Tarekegn, Santra Saikat, Banka Siddarth, Cox Timothy M., Cox T. M., Platt F. M., Banka S., Chakrapani A., Deegan P. B., Geberhiwot T., Hughes D. A., Jones S., Lachmann R. H., Santra S., Sharma R., Vellodi A., In-depth phenotyping for clinical stratification of Gaucher disease, Orphanet Journal of Rare Diseases, 16, 1, 2021. Crossref

  59. Ryan Emory, Nguyen My-Le, Lopez Grisel, Mitchell Kathleen, Lowery Margaret, Singh Suma, Cholewa Anna, Bandettini W. Patricia, Moore Charles, Sidransky Ellen, Gaucher Disease and Heart Failure of Unknown Origin, The American Journal of Medicine, 134, 6, 2021. Crossref

  60. Nascimbeni Fabio, Dalla Salda Annalisa, Carubbi Francesca, Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  61. Lorenz Fryderyk, Pawłowicz Ewa, Klimkowska Monika, Beshara Soheir, Bulanda Brustad Agnes, Skotnicki Aleksander B., Wahlin Anders, Machaczka Maciej, Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  62. Barootes Hailey C., Prasad Chitra, Rupar C. Anthony, Ashok Dhandapani, An Unexpected Finding of Hepatosplenomegaly in a Pediatric Patient, Clinical Pediatrics, 61, 1, 2022. Crossref

  63. Messelodi Daria, Bertuccio Salvatore Nicola, Indio Valentina, Strocchi Silvia, Taddia Alberto, Serravalle Salvatore, Bandini Jessica, Astolfi Annalisa, Pession Andrea, iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death, Cells, 10, 11, 2021. Crossref

  64. Parolo Silvia, Tomasoni Danilo, Bora Pranami, Ramponi Alan, Kaddi Chanchala, Azer Karim, Domenici Enrico, Neves-Zaph Susana, Lombardo Rosario, Reconstruction of the Cytokine Signaling in Lysosomal Storage Diseases by Literature Mining and Network Analysis, Frontiers in Cell and Developmental Biology, 9, 2021. Crossref

  65. Owaidah Tarek, Alabbas Fahad, Alhazmi Iman, Al Saeed Hussain, Balelah Saud, ElYamany Ghaleb, Kashari Ohoud, Qari Mohamad, Saleh Mahasen, Roushdy Sherif, ElBagoury Marwan, Diagnosis and management of hematological manifestations of gaucher disease: Insights from Saudi Arabia, Journal of Applied Hematology, 12, 3, 2021. Crossref

  66. Zhang Ziqi, Yue Pengfei, Lu Tianqi, Wang Yang, Wei Yuquan, Wei Xiawei, Role of lysosomes in physiological activities, diseases, and therapy, Journal of Hematology & Oncology, 14, 1, 2021. Crossref

  67. Jasiński Marcin, Biliński Jarosław, Basak Grzegorz W., The Role of the Crosstalk Between Gut Microbiota and Immune Cells in the Pathogenesis and Treatment of Multiple Myeloma, Frontiers in Immunology, 13, 2022. Crossref

  68. Kishnani Priya S., Al-Hertani Walla, Balwani Manisha, Göker-Alpan Özlem, Lau Heather A., Wasserstein Melissa, Weinreb Neal J., Grabowski Gregory, Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus, Molecular Genetics and Metabolism, 135, 2, 2022. Crossref

  69. Lin Wei-De, Tsai Fuu-Jen, Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study, Biomedicine Hub, 6, 3, 2021. Crossref

  70. Portier Elodie, Talbot Alexis, Nguyen Yann, Royer Bruno, Pettazzoni Magali, Ben Salah Imen, Trichet Catherine, Vercellino Laetitia, Arnulf Bertrand, Belmatoug Nadia, Multiple myeloma occurring in a case of Niemann‐Pick disease Type B: A pathophysiological link?, British Journal of Haematology, 197, 4, 2022. Crossref

  71. Weinreb Neal J., Goker-Alpan Ozlem, Kishnani Priya S., Longo Nicola, Burrow T. Andrew, Bernat John A., Gupta Punita, Henderson Nadene, Pedro Helio, Prada Carlos E., Vats Divya, Pathak Ravi R., Wright Ekaterina, Ficicioglu Can, The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?, Molecular Genetics and Metabolism, 136, 1, 2022. Crossref

  72. Zhao Xueheng, Brusadelli Marion G., Sauter Sharon, Butsch Kovacic Melinda, Zhang Wujuan, Romick-Rosendale Lindsey E., Lambert Paul F., Setchell Kenneth D.R., Wells Susanne I., Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells, Clinical Cancer Research, 24, 11, 2018. Crossref

  73. Panaroni Cristina, Fulzele Keertik, Mori Tomoaki, Siu Ka Tat, Onyewadume Chukwuamaka, Maebius Allison, Raje Noopur, Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins, Blood, 139, 6, 2022. Crossref

  74. Jerves Teodoro, Blau Nenad, Ferreira Carlos R., Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias, Molecular Genetics and Metabolism, 136, 2, 2022. Crossref

  75. Dura Miroslav, Pock Lumir, Cetkovska Petra, Jungova Alexandra, Nemejcova Kristyna, Stork Jiri, A case of cutaneous collagenous vasculopathy associated with multiple myeloma and with a pathogenic variant of the glucocerebrosidase gene, Journal of Cutaneous Pathology, 49, 8, 2022. Crossref

  76. Lucari Brandon, Tallis Eran, Sutton Vernon Reid, Porea Timothy, Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma, Pediatric Hematology and Oncology, 2022. Crossref

  77. Rosenbloom Barry E., Cappellini Maria Domenica, Weinreb Neal J., Dragosky Marta, Revel‐Vilk Shoshana, Batista Julie L., Sekulic Davorka, Mistry Pramod K., Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry, American Journal of Hematology, 97, 10, 2022. Crossref

  78. Cox Timothy M., Lysosomal Diseases, in Encyclopedia of Cell Biology, 2023. Crossref

  79. Uzen Ramazan, Bayram Fahri, Dursun Huseyin, Kardas Fatih, Altın-Celik Pınar, Cakir Mustafa, Eken Ahmet, Cucer Nurhan, Donmez-Altuntas Hamiyet, Oxidative and chromosomal DNA damage in patients with type I Gaucher disease and carriers, Clinical Biochemistry, 111, 2023. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain